Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes

Leukemia Research

Volumn 23, Issue 6, 1999, Pages 579-584

  Hast, Robert ^a   Eriksson, Maria ^a   Widell, Susanne ^b   Arvidsson, Ingrid ^a   Bemell, Per ^a  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chromosomes; Dysplasia; Fluorescence in situ hybridization; Granulocytes; Hypogranulation; Monosomy 7; Myelodysplastic syndromes; Pelgeroid abnormalities; Trisomy 8

Indexed keywords

ARTICLE; BONE MARROW; CHROMOSOME ABERRATION; CHROMOSOME MARKER; CLONE; CONTROLLED STUDY; DYSPLASIA; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; KARYOTYPE; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; PRIORITY JOURNAL; TRISOMY 8;

AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 8; CLONING, MOLECULAR; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEUTROPHILS; TRISOMY;

EID: 0033035824     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)00042-9     Document Type: Article

References (22)

1. Bennett J.M., Catovsky D., Daniel M.T, Handrin G., Galton D.A.G., Gralnick H.R. et al. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 51:1982;189.
2. Pagliuca A., Mufti G.J. Clinicomorphological features of myelodysplastic syndromes. Mufti G.J., Galton D.A.G. The Myelodysplastic Syndromes. 1992;Churchill Livingstone, Edinburgh.
3. Tricot G., Boogerts M.A., De Wolf-Peeters C., Van den Berghe H., Verwilghen R.L. The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations. Br. J. Haematol. 59:1985;659.
4. Jacobs R.H., Conbleet M.A., Vardiman J.W., Larson R.A., Le Beau M.M., Rowley J.D. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood. 67:1986;1765.
5. Hast R., Nilsson I., Widell S., Öst Å. Diagnostic significance of dysplastic features of peripheral blood polymorphs in myelodysplastic syndromes. Leuk. Res. 13:1989;173.
6. Widell S., Hellstrom-Lindberg E., Kock Y., Lindberg M., Öst Å., Hast R. Peripheral blood neutrophil morphology reflects bone marrow dysplasia in myelodysplastic syndromes. Am. J. Hematol. 49:1995;115.
7. Goasguen J.E., Bennett J.M. Classification and morphologic features of the myelodysplastic syndromes. Semin. Oncol. 19:1992;4.
8. Hast R., Widell S. Dysplastic peripheral blood polymorphs link acute myeloblastic leukemia in elderly to the myelodysplastic syndromes. Eur. J. Haematol. 48:1992;163.
9. Raza A., Gezer S., Mundle S., Gao X.Z., Alvi S., Borok R. et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood. 86:1995;268.
10. Bowen D. What is ineffective erythropoiesis in myelodysplastic syndromes? Leuk. Lymph. 18:1995;243.
11. Hellström-Lindberg E., Kanthor-Lewensohn L., Öst Å. Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin. Leuk. Res. 21:1997;415.
12. Asano H., Ohashi H., Ishihara M., Kinoshita T., Murate T., Kobayashi M. et al. Evidence for non-clonal hematopoietic progenitor cell population in bone marrow of patients with myelodysplastic syndromes. Blood. 84:1994;588.
13. Ito T., Ohashi H., Kagami Y., Ichikawa A., Saito H., Hotta T. Recovery of polyclonal heamtopoiesis in patients with myelodysplastic syndromes following successful chemothrapy. Leukemia. 8:1994;839.
14. Jacobsson B., Bernell P., Arvidsson I., Hast R. Classical morphology, esterase cytochemistry and interphase cytogenetics of peripheral blood and bone marrow smears. J. Histochem. Cytochem. 44:1996;1303.
15. ISCN. Guidelines for cancer cytogenetics. In: Mitelman F, editor. An International System for Human Cytogenetic Nomenclature (Supplement). Basel: S Karger, 1996.
16. Greenberg P., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G. et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 89:1997;2079.
17. Bernell P., Jacobsson B., Nordgren A., Hast R. Studies of cell lineage involvement in myelodysplastic syndromes by combination of fluorescence in situ hybridization (FISH) and classical cell morphology. Leukemia. 10:1996;662.
18. Lai J.L., Preudhomme C., Zandecki M., Flactif M., Vanrumbeke M., Lepelley P. et al. Myelodysplastic syndromes and acute leukemia with 17p deletion. An entity characterized by specific dysgranulopoiesis and a high incidnece of p53 mutations. Leukemia. 9:1995;370.
19. Janssen J.W., Buschle M., Layton M., Drexler H.G., Lyons J., Van den Berghe H. et al. Clonal analysis of myelodysplastic syndromes: Evidence of multipotent stem cell origin. Blood. 73:1989;248.
20. Fearon E.R., Burke P.J., Schiffer C.A., Zehnbauer B.A., Vogelstein B. Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. New Engl. J. Med. 315:1986;15.
21. Soenen V., Fenaux P., Flactif M., Lepelley P., Lai J.L., Cosson A. et al. Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes. Br. J. Haematol. 90:1995;701.
22. Widell S., Hast R. Balloon-like platelets in myelodysplastic syndromes - a feature of dysmegakaryopoiesis? Leuk. Res. 11:1987;747.